Expression of somatostatin receptor subtype 3 in the gastric mucosa of dyspeptic patients in relation to Helicobacter pylori infection and a family history of gastric cancer

Journal of Gastroenterology and Hepatology (Australia)

Volumn 23, Issue 3, 2008, Pages 424-429

  Stec Michalska, Krystyna ^a   Peczek, Lukasz ^b   Krakowiak, Agnieszka ^b   Michalski, Blazej ^b   Chojnacki, Jan ^a   Knopik Dabrowicz, Alina ^a   Klupinska, Grazyna ^a   Nawrot, Barbara ^b  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b CENTRE OF MOLECULAR AND MACROMOLECULAR STUDIES   (Poland)

Author keywords

Dyspepsia; Family history of gastric cancer; Helicobacter pylori; Somatostatin receptor subtype 3 (SSTR3)

Indexed keywords

MESSENGER RNA; SOMATOSTATIN RECEPTOR 3;

ADULT; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DYSPEPSIA; ENVIRONMENTAL FACTOR; FAMILY HISTORY; FEMALE; GENE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; RECEPTOR DENSITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SSTR3 GENE; STOMACH ANTRUM; STOMACH CANCER; STOMACH FUNDUS; STOMACH MUCOSA;

EID: 40349087545     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2007.05094.x     Document Type: Article

References (25)

1. 1 Taniyama Y, Suzuki T, Mikami Y, Moriya T, Satomi S, Sasano H. Systemic distribution of somatostatin receptor subtypes in human: an immunohistochemical study. Endocr. J. 2005 ; 52: 605–11.
2. 2 Patel YC. Somatostatin and its receptor family. Front. Neuroendocrinol. 1999 ; 20: 157–98.
3. 3 Reubi JC, Laissue J, Krenning E, Lamberts SW. Somatostatin receptors in human cancer: incidence, characteristics, functional correlates and clinical implications. J. Steroid Biochem. Mol. Biol. 1992 ; 43: 27–35.
4. 4 Hu C, Yi C, Hao Z et al. The effect of somatostatin and SSTR3 on proliferation and apoptosis of gastric cancer cells. Cancer Biol. Ther. 2004 ; 3: 726–30.
5. 5 Stec‐Michalska K, Antoszczyk S, Klupinska G, Nawrot B. Loss of FHIT expression in gastric mucosa of patients with family histories of gastric cancer and Helicobacter pylori infection. World J. Gastroenterol. 2005 ; 11: 17–21.
6. 6 Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am. J. Surg. Pathol. 1996 ; 20: 1161–81.
7. 7 Chowen‐Breed JA, Steiner RA, Clifton DK. Sexual dimorphism and testosterone‐dependent regulation of somatostatin gene expression in the periventricular nucleus of the rat brain. Endocrinology 1989 ; 125: 357–62.
8. 8 Señaris RM, Diéguez C. Gonadal regulation of somatostatin receptor 1, 2 and 3 mRNA levels in the rat anterior pituitary. Mol. Brain Res. 1996 ; 38: 171–5.
9. 9 Lago F, Señaris RM, Emson PC, Dominguez F, Diéguez C. Evidence for the involvement of non‐androgenic testicular factors in the regulation of hypothalamic somatostatin and GHRH mRNA levels. Mol. Brain Res. 1996 ; 35: 220–6.
10. 10 Ramirez JL, Grant M, Norman M et al. Deficiency of somatostatin (SST) receptor type 5 (SSTR5) is associated with sexually dimorphic changes in the expression of SRIH and SRIH receptors in brain and pancreas. Mol. Cell. Endocrinol. 2004 ; 221: 105–19.
11. 11 Lahlou H, Guillermet J, Hortala M et al. Molecular signaling of somatostatin receptors. Ann. N. Y. Acad. Sci. 2004 ; 1014: 121–31.
12. 12 Zavros Y, Rieder G, Ferguson A, Samuelson LC, Merchant JL. Hypergastrinemia in response to gastric inflammation suppresses somatostatin. Am. J. Physiol. Gastrointest. Liver Physiol. 2002 ; 282: G175–83.
13. 13 Moss SF, Legon DS. Effect of H. pylori on gastric somatostatin in duodenal ulcer disease. Lancet 1992 ; 340: 930–2.
14. 14 Milutinovic AS, Todorovic V, Milosavljevic T, Micev M, Spuran M, Drndarevic N. Somatostatin and D cells in patients with gastritis in the course of Helicobacter pylori eradication: a six‐month, follow‐up study. Eur. J. Gastroenterol. Hepatol. 2003 ; 15: 755–66.
15. 15 Zavros Y, Merchant JL. Modulating the cytokine response to treat Helicobacter pylori. Biochem. Pharmacol. 2005 ; 69: 365–71.
16. 16 Florio T, Morini M, Villa V et al. Somatostatin inhibits tumor angiogenesis and growth via somatostatin receptor‐3‐mediated regulation of endothelial nitric oxide synthase and mitogen‐activated protein kinase activities. Endocrinology 2003 ; 144: 1574–84.
17. 17 Qiu CZ, Wang C, Huang ZX, Zhu SZ, Wu YY, Qiu JL. Relationship between somatostatin receptor subtype expression and clinicopathology, Ki‐67, Bcl‐2 and p53 in colorectal cancer. World J. Gastroenterol. 2006 ; 12: 2011–15.
18. 18 Crowe SE. Helicobacter infection, chronic inflammation, and the development of malignancy. Curr. Opin. Gastroenterol. 2005 ; 21: 32–8.
19. 19 Zambon CF, Basso D, Navaglia F et al. Pro‐ and anti‐inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome. Cytokine 2005 ; 29: 141–52.
20. 20 Houghton JM, Wang TC. Helicobacter pylori and gastric cancer: a new paradigm for inflammation‐associated epithelial cancers. Gastroenterology 2005 ; 128: 1567–78.
21. 21 Wong BC, Lam SK, Wong WM et al. Helicobacter pylori eradication to prevent gastric cancer in a high‐risk region of China: a randomized controlled trial. JAMA 2004 ; 291: 187–94.
22. 22 Hojo M, Miwa H, Ohkusa T, Ohkura R, Kurosawa A, Sato N. Alteration of histological gastritis after cure of Helicobacter pylori infection. Aliment. Pharmacol. Ther. 2003 ; 17: 1331–2.
23. 23 Baffa R, Veronese ML, Santoro R et al. Loss of FHIT expression in gastric carcinoma. Cancer Res. 1998 ; 58: 4708–14.
24. 24 Lee SH, Kim WH, Kim HK et al. Altered expression of the fragile histidine triad gene in primary gastric adenocarcinomas. Biochem. Biophys. Res. Commun. 2001 ; 284: 850–5.
25. 25 Benali N, Ferjoux G, Puente E, Buscail L, Susini C. Somatostatin receptors. Digestion 2000 ; 62 (Suppl. 1): 27–32.